Most Recent Articles about LLY
J&J's Stelara Gets EU Nod for Plaque Psoriasis in Children http://www.zacks.com/stock/news/731608/jjs-stelara-gets-eu-nod-for-plaque-psoriasis-in-children?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-731608 Jan 24, 2020 - Johnson & Johnson (JNJ) receives the European Commission's (EC) nod to the line extension of Stelara to treat six to 11-year-old pediatric patients with moderate-to-severe plaque psoriasis.
Top Stock Analyst Reports for Pfizer, Wells Fargo & SAP http://www.zacks.com/research-daily/729250/top-stock-analyst-reports-for-pfizer-wells-fargo-sap?cid=CS-ZC-FT-research_daily-729250 Jan 22, 2020 - Top Stock Analyst Reports for Pfizer, Wells Fargo & SAP
Eli Lilly's Shopping Spree Won't Stop With Dermira, CFO Shares Plans For More Deals In 2020 https://www.fool.com/investing/2020/01/17/eli-lillys-shopping-spree-wont-stop-with-dermira-c.aspx?source=iedfolrf0000001 Jan 17, 2020 - The Midwest's largest drugmaker isn't finished making mid-sized deals.

Related Companies

Name Exchange Price Mkt Cap
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
SNY Sanofi NYSE $43.75 $109.14B
ABT Abbott Laboratories NYSE $67.67 $118.71B
BMY Bristol-Myers Squibb Company NYSE $61.3 $100.03B
GSK GlaxoSmithKline PLC NYSE $39.21 $97.25B
Sector: Health Care > Industry: Major Pharmaceuticals